EZZ Life Science Holdings Limited (ASX:EZZ)

Market Cap	29.18M -55.2%
Revenue (ttm)	61.40M -18.2%
Net Income	2.89M -67.9%
EPS	0.06 -69.8%
Shares Out	47.07M
PE Ratio	10.11
Forward PE	n/a
Dividend	0.04 (6.40%)
Ex-Dividend Date	Nov 24, 2025

Volume	13,637
Average Volume	24,682
Open	0.6300
Previous Close	0.6200
Day's Range	0.6100 - 0.6350
52-Week Range	0.5650 - 3.3800
Beta	0.83
RSI	37.65
Earnings Date	May 28, 2026

About EZZ Life Science Holdings

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. Th...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EZZ

Financial Performance

In fiscal year 2025, EZZ Life Science Holdings's revenue was 66.87 million, an increase of 0.65% compared to the previous year's 66.44 million. Earnings were 6.73 million, a decrease of -3.36%.